Contravisory Investment Management’s Universal Health Services UHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,438
Closed -$617K 454
2024
Q4
$617K Buy
3,438
+1,336
+64% +$272K 0.13% 104
2024
Q3
$481K Buy
+2,102
New +$453K 0.1% 145
2023
Q4
Sell
-2,775
Closed -$349K 421
2023
Q3
$349K Buy
+2,775
New +$379K 0.1% 145
2021
Q4
Sell
-588
Closed -$81K 321
2021
Q3
$81K Buy
588
+559
+1,928% +$84.6K 0.02% 221
2021
Q2
$4K Buy
+29
New +$4.38K ﹤0.01% 260
2020
Q1
Sell
-29,950
Closed -$4.3M 322
2019
Q4
$4.3M Buy
29,950
+353
+1% +$50.3K 1.57% 35
2019
Q3
$4.4M Sell
29,597
-233
-0.8% -$33.5K 1.67% 28
2019
Q2
$3.89M Sell
29,830
-4,673
-14% -$588K 1.5% 37
2019
Q1
$4.62M Sell
34,503
-663
-2% -$87.3K 1.79% 22
2018
Q4
$4.1M Sell
35,166
-788
-2% -$99K 1.77% 26
2018
Q3
$4.6M Buy
35,954
+33,191
+1,201% +$4.07M 1.65% 28
2018
Q2
$308K Buy
+2,763
New +$324K 0.11% 123

Other funds holding UHS

Contravisory Investment Management's UHS Position: Q1 2025 in Review

Contravisory Investment Management sold out of Universal Health Services (UHS) in Q1 2025, closing a stake of 3,438 shares — an estimated $617K sold.

Contravisory Investment Management first reported a position in UHS in Q2 2018 and held it in 12 quarters. The position peaked at $4.62M in Q1 2019. 617 funds tracked by Wall St. Rank hold UHS as of Q1 2025.

  • Contravisory Investment Management reported no remaining Universal Health Services position as of Q1 2025 after selling out during the quarter.
  • Contravisory Investment Management sold 3,438 Universal Health Services shares in Q1 2025, an estimated $617K.
  • Contravisory Investment Management first reported a position in Universal Health Services in Q2 2018 and held it in 12 quarters.
  • Contravisory Investment Management's Universal Health Services position peaked at $4.62M in Q1 2019.
  • 617 funds tracked by Wall St. Rank held Universal Health Services as of Q1 2025.

Based on Contravisory Investment Management's 13F filing for Q1 2025, filed 10 Apr 2025.